Showing results (361-370 of 420) with videos related to
Sort By:
Pageof 42
Journal for Immunotherapy of Cancer|February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J Luke, Fabrice Barlesi, Ki Chung, et al.Journal of the National Cancer Institute|September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing SarcomaSalah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2018
Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient SurvivalVivek Subbiah, Salah-Eddine Lamhamedi-Cherradi, Branko Cuglievan, et al.Nature Reviews. Clinical Oncology|December 9, 2024
Leptomeningeal metastatic disease: new frontiers and future directionsAhmad Ozair, Hannah Wilding, Debarati Bhanja, et al.JCO Global Oncology|January 23, 2025
Precision Oncology: A Global Perspective on Implementation and Policy DevelopmentDenis Horgan, Marcel Tanner, Charu Aggarwal, et al.Journal of Immunotherapy and Precision Oncology|February 8, 2023
Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical CancerJi Son, Heather Y Lin, Siqing Fu, et al.Oncology|May 22, 2016
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid CarcinomaAndreas M Heilmann, Vivek Subbiah, Kai Wang, et al.JCI Insight|April 20, 2017
First-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patientsVivek Subbiah, Muhammad Rizwan Khawaja, David S Hong, et al.Journal of Immunotherapy and Precision Oncology|February 17, 2025
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I TrialMirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.Cancer Medicine|February 13, 2025
A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell CarcinomaOmar Alhalabi, Mohamed A Gouda, Denái R Milton, et al.Pageof 42